Technologies

In this section it is possible to view, also through targeted research, the technologies inserted in the PROMO-TT Database. For further information on the technologies and to contact the CNR Research Teams who developed them, it is necessary to contact the Project Manager (see the references at the bottom of each record card).

Displaying results 1 - 4 of 4

# Record card
159
Description

The development of genome editing tools has revolutionized the way we think and deal with genetics. The use of Cas9 or its variants allows modifications of specific sites in the human genome by inducing deletions and insertions in a more or less controlled way. In recent years, a new class of tools for genome editing has emerged: the base editors (BE), which result from the fusion of a modified Cas9, which serves to direct the BE to the target, and an active deaminase acting on the DNA, which mediates the C> T or A> G editing.

Thematic areas
Health & Biotech
Health & Biotech / Bio-medicals
Health & Biotech / New therapies
Health & Biotech / Diagnostic kits
# Record card
89
Description

Nowadays, to properly design and develop advanced materials capable to preserve for long times their performance under aggressive environments such as power generation plants, renewables, nuclear reactors and electronics of new generation, transport on ground and on space, aeronautics, catalysis, biomedical implants, the optimization of metallurgical processes involved is crucial.

Thematic areas
Aerospace and Earth Science / Space sciences
Aerospace and Earth Science / Aeronautical technologies and avionics
Aerospace and Earth Science / Satellite technologies
Automotive transport and logistics / Vehicles
Automotive transport and logistics / Shipbuilding
Automotive transport and logistics / Propulsion
Automotive transport and logistics / Transport infrastructures
Additive and advanced industrial manufacturing / Additive manufacturing processes and materials
Additive and advanced industrial manufacturing / Vacuum/High vacuum technologies
Chemicals & Physics / Inorganic substances
Chemicals & Physics / Man made fibres
Chemicals & Physics / Special chemicals
Chemicals & Physics / Subtainable substances and green chemistry
Materials / Building materials
Materials / Ceramic materials
Materials / Composite and hybrid materials
Materials / Metals & alloys
Materials / Properties of materials, corrosion, degradation
Materials / Semiconductors and Superconductors
Energy and environmental sustainability / Renewable sources
Energy and environmental sustainability / Rational use of energy
Energy and environmental sustainability / Nuclear fission/nuclear fusion
Energy and environmental sustainability / Cleaner use of fossil fuels
Energy and environmental sustainability / Nuclear engineering
Energy and environmental sustainability / Safety and security
Energy and environmental sustainability / Environmental engineering/technologies
Energy and environmental sustainability / Building materials
Health & Biotech / Bio-medicals
# Record card
27
Description

The dramatic global health emergency due to the SARS-CoV-2 pandemic requires new diagnostic devices capable of identifying the presence of virus particles in patient biological samples. In this direction, the development of an innovative low-cost test, which provides the result within a few minutes, which is reproducible and which can reveal the direct presence of even a few viral particles, would be of fundamental importance for the monitoring and containment of the pandemic.

Thematic areas
Health & Biotech / Micro and nanotechnology related to biological sciences
ICT & Electronics / Sensor/multi-sensor technology, instrumentation
Health & Biotech / Bio-medicals
Health & Biotech / Diagnostic kits
ICT & Electronics / Big Data
Health & Biotech / Smart Devices for Health and Wellness
Health & Biotech / Diagnostic, Medical imaging & advanced bioimaging
Health & Biotech / Medical Device
Health & Biotech / Biosensors
# Record card
31
Description

The assessment of bio-humoral markers beyond clinical evaluation would allow a more comprehensive pheno/endotyping of patients affected by chronic inflammatory diseases. Therapy personalization would require a profile of the mediators that are relevant in the disease pathogenesis and that well correlate with prognosis. Currently, the measurement of multiple biomarkers is not included in patient evaluation because it has high costs,  requires centralized laboratories, experienced personnel and bulky equipment and is time-consuming.

Thematic areas
Health & Biotech / Bio-medicals
Health & Biotech / Smart Devices for Health and Wellness
Health & Biotech / Biosensors